Protein Component of Oyster Glycogen Nanoparticles: An Anchor Point for Functionalization.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
02 Sep 2020
Historique:
pubmed: 19 8 2020
medline: 18 2 2021
entrez: 19 8 2020
Statut: ppublish

Résumé

Biosourced nanoparticles have a range of desirable properties for therapeutic applications, including biodegradability and low immunogenicity. Glycogen, a natural polysaccharide nanoparticle, has garnered much interest as a component of advanced therapeutic materials. However, functionalizing glycogen for use as a therapeutic material typically involves synthetic approaches that can negatively affect the intrinsic physiological properties of glycogen. Herein, the protein component of glycogen is examined as an anchor point for the photopolymerization of functional poly(

Identifiants

pubmed: 32805918
doi: 10.1021/acsami.0c10699
doi:

Substances chimiques

Acrylic Resins 0
poly-N-isopropylacrylamide 25189-55-3
Glycogen 9005-79-2
Amylases EC 3.2.1.-
Peptide Hydrolases EC 3.4.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38976-38988

Auteurs

Quinn A Besford (QA)

Leibniz Institute for Polymer Research, Hohe Straße 6, 01069 Dresden, Germany.

Alessia C G Weiss (ACG)

Leibniz Institute for Polymer Research, Hohe Straße 6, 01069 Dresden, Germany.

Jonas Schubert (J)

Leibniz Institute for Polymer Research, Hohe Straße 6, 01069 Dresden, Germany.

Timothy M Ryan (TM)

The Australian Synchrotron, Clayton, Victoria 3168, Australia.

Manfred F Maitz (MF)

Leibniz Institute for Polymer Research, Hohe Straße 6, 01069 Dresden, Germany.

Pietro Pacchin Tomanin (PP)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.

Marco Savioli (M)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.

Carsten Werner (C)

Leibniz Institute for Polymer Research, Hohe Straße 6, 01069 Dresden, Germany.

Andreas Fery (A)

Leibniz Institute for Polymer Research, Hohe Straße 6, 01069 Dresden, Germany.

Frank Caruso (F)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia.

Francesca Cavalieri (F)

School of Science, RMIT University, Melbourne, Victoria 3000, Australia.
Dipartimento di Scienze e Tecnologie Chimiche, Università di Roma "Tor Vergata", Via Della Ricerca Scientifica 1, 00133 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH